2015 zhong guo sheng wu zhi pin nian hui zuo di shi wu ci quan guo sheng wu zhi pin xue shu yan tao hui zai shen zuo cheng gong zhao kai

..............page:2637-2639

di qi jie zhong de fei ai lun tan (cglcf) zhuan fang bao dao

..............page:2640

A new drug for non-small-cell lung cancer: ceritinib
LI Wen-han;DU Xiao-li;Peiking Union Medical College Hospital;Peking Union Medical College;Chinese Academy of Medical Sciences;

..............page:2641-2644

zhong guo xin yao za zhi ru xuan guo jia ke ji bu 2014 nian du ling pao zhe 5000 zhong guo jing pin ke ji qi kan ding jian xue shu lun wen ping tai (f5000) wen zhang jian jie

..............page:2644+2655+2663

Budget impact analysis of tafluprost after its introduction into market
LIN Qi-min;HAN Sheng;GUAN Xiao-dong;MA Li-li;ZHAO Liang;SHI Lu-wen;Peking University School of Pharmaceutical Sciences;International Research Center of Medicinal Administration;

..............page:2645-2650

The development status,challenges and countermeasures of Ginkgo Biloba extract market in China
SONG Yang;YU Zhi-bin;YOU Xiao-min;YANG Yue;School of Business Administration;Shenyang Pharmaceutical University;China Chamber of Commerce for Import & Export of Medicines & Health Products;

..............page:2651-2655

Analysis of risk-love-type manufacturer-involved multiplayer game under the regulation of self-check on clinical data
YAN Ke-shu;HOU Peng;China Food and Drug Administration Institute of Executive Development;School of Social Science;Tsinghua University;Center for Drug Evaluation;China Food and Drug Administration;

..............page:2656-2659

Considerations of technical evaluation and clinical trials for seasonal inactivated influenza vaccines
WANG Zhao-yun;AI Xing;YANG Zhi-min;YANG Huan;Center for Drug Evaluation;China Food and Drug Administration;

..............page:2660-2663

Main influence factors on alkaline comet assay
HAN Tian-jiao;ZHOU Chang-hui;CHANG Yan;Chinese State Institute of Pharmaceutical Industry;National Shanghai Center for New Drug Safety Evaluation Research;

..............page:2664-2668

Advances in fast onset antidepressants
HUANG Ji-sheng;DU Jin-ping;XU Yan-tong;Tianjin Key Laboratory of Modern Chinese Medicine;Tianjin University of Traditional Chinese Medicine;Research and Development Center of TCM;Tianjin International Joint Academy of Biotechnology and Medicine;

..............page:2669-2676

Pharmacokinetics of methylphenidate hydrochlorideoral oral fast dissolving films in rats
ZHANG Li-hong;WU Na;XU Ping-hua;CHENG Ling;SHEN Gang;LI Juan-juan;QIU Ling;ZHENG Juan;ZHANG Shi-long;YUAN Hai-long;HAN Jin;Jiangxi University of Traditional Chinese Medicine;302 Military Hospital of China;

..............page:2677-2680

Quality control of components of pneumococcal capsular polysaccharide vaccines by ~1H-NMR spectroscopic method
WANG-Xi;LI A-ni;ZHANG Yi;ZHANG Xin-zhuang;REN Ke-ming;WANG Jian-hong;SHEN Rong;Lanzhou Institute of Biological Products Co.;Ltd.;Center for Gansu Provincial Vaccine Engineering Research;

..............page:2681-2686

Advances of thrombolytics in acute phase of ischemic stroke
HAO Chun-hua;LI Ya-li;SUN Shuang-yong;WANG Wei-ting;ZHAO Zhuan-you;Tianjin Center for Drug Safety Evaluation and Research;Tianjin Institute of Pharmaceutical Research;

..............page:2687-2691

Sample size in average bioequivalence test of pharmaceutical preparations
YANG Man;DU Ai-hua;ZHANG Ya-nan;MENG Ling-jie;XU Juan;LIU Hui-chen;Department of Clinical Pharmacology;Aerospace Center Hospital;

..............page:2692-2694+2728

Recent progress in GPR119 agonists for type 2 diabetes
FANG Yuan-ying;SHAO Feng;LIU Rong-hua;YANG Zun-hua;College of Pharmacy;Jiangxi University of Traditional Chinese Medicine;

..............page:2695-2703+2723

Clinical analysis of alprostadil and mecobalamin for the treatment of diabetic ophthalmoplegia
SHI Su-qin;CHEN Xiao-fei;GAO Xiao-jie;GONG Yang-yang;GUI Xin-jing;MENG Xiang-le;ZHANG Xiao-dong;The First Affiliated Hospital of Henan College of Traditional Chinese Medicine;Henan College of TCM;

..............page:2704-2707

Preparation of targeted ursolic acid liposomes modified with folate derivative and their inhibitory effect on human epidermoid carcinoma
YANG Guang;ZHANG Tao;CHEN Xiao-qing;School of Medicine;Jianghan University;Pharmacy School;Tongji Medical College;Huazhong University of Science and Technology;

..............page:2708-2714

Metabolism of Formononetin in Millettia nitida Benth. var. hirsutissima Z. Wei extract co-incubated with rat intestinal flora by UPLC / Q-TOF-MS / MS
LIU Ya-li;WEI Shao-feng;SONG Yong-gui;LI Wei;WANG Meng;ZHANG Ling;YANG Shi-lin;SU Dan;Jiangxi University of Chinese Traditional Medicine;Science and Technology College;Jiangxi University of Chinese Traditional Medicine;the National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine;

..............page:2715-2723

Screening of SIRT5 inhibitors from natural products
HUANG Wen-fei;YOU Ling;ZHU Hong;LIAO Shang-gao;LI Yong-jun;LIU Ting;WANG Ai-min;HE Bin;LAN Yan-yu;Engineering Research Center for the Development and Application of Ethnic Medicine Guizhou Medical University;College of Pharmacy;TCM Guizhou Medical University;Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University;

..............page:2724-2728

Study on the quality standard of Compound Tiancha Jiangzhi Mixture
LIU Fan;WANG Shuo;CAI Jin-yuan;GONG Xiao-mei;FAN Xi-yuan;ZHOU Xiao-lei;Guangxi Botanical Garden of Medicinal Plants;Guangxi Key Laboratory of Medicinal Resources Protection and Genetic Improvement;College of Lushan;Guangxi University of Science and Technology;

..............page:2729-2732+2745

Preparation of temperature-sensitive glycyrrhetinic acid-chitosan drug carrier and study on its micellar properties
MA Ya-ping;HUANG Yi-ping;ZHAO Cheng-lei;WANG Li;XU Jia;Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Nanjing University of Chinese Medicine;Jiangsu Province Academy of Traditional Chinese Medicine and Jiangsu Branch of China Academy of Chinese Medical Sciences;

..............page:2733-2739

Preparation,characterization and antitumor effects of fluorouracil-loaded small size stealth niosomes
GONG Zhu-ping;L Xiao-yan;YANG Hong;LUO Geng;LIU Di;ZHAO Cheng-long;XING Xi-xi;SONG Xue;HUANG Li;College of Pharmaceutical Sciences;Soochow University;

..............page:2740-2745

Effects of ADR Notification on purchase amount of three drugs in Beijing sample hospitals
CONG Luo-luo;LI Hong-yao;BAI Yu-xia;SHAO Ming-li;International Pharmaceutical Business School of China Pharmaceutical University;Beijing Food and Drug Administration;School of Pharmaceutical Sciences;Peking University;

..............page:2746-2750+2760

Effectiveness,safety and economy of saxagliptin in type 2 diabetes: a rapid health technology assessment
MEN Peng;TANG Hui-lin;ZHAI Suo-di;Department of Pharmacy;Peking University Third Hospital;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Science;Peking University;

..............page:2751-2755

Study on tablet splitting of 13 children hospitals and suggestion on establishing children-friendly drug specifications for common pediatric drugs
LI Ying;JIA Lu-lu;HU Bo-yang;WANG Xiao-ling;Beijing Children’s Hospital;Capital Medical University;

..............page:2756-2760

2014-2015 nian xin yao shen bao yu shen ping ji shu lun wen xuan ji zheng ding qi shi

..............page:2762